Trials / Unknown
UnknownNCT03589157
Comparison of Safety and Efficacy of Coronary Drug-coated Balloon (DCB) Combined With Spot Stenting of Drug-eluting Stent (DES) Versus Second-generation DES for Treating Diffuse Coronary Artery Lesions: a Prospective, Randomized, Controlled Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- Chinese PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The prospective, randomized, controlled clinical trial aims to evaluate the safety and efficacy of paclitaxel-eluting PTCA-balloon catheter (SeQuent® Please) combined with provisional spot stenting of DES versus DES for treating diffuse coronary artery lesions concerning interventional therapy and vessel patency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | drug-coated balloon (DCB) combined with spot stenting of drug-eluting stent (DES) | using drug-coated balloon (DCB) combined with spot stenting of drug-eluting stent (DES) for treating diffuse coronary artery lesions |
| DEVICE | drug-coated balloon (DCB) combined with second-generation of drug-eluting stent (DES) | using drug-coated balloon (DCB) combined with second-generation DES for treating diffuse coronary artery lesions |
Timeline
- Start date
- 2018-07-15
- Primary completion
- 2021-06-30
- Completion
- 2022-06-30
- First posted
- 2018-07-17
- Last updated
- 2018-07-17
Source: ClinicalTrials.gov record NCT03589157. Inclusion in this directory is not an endorsement.